These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21331942)

  • 1. Methodological aspects of multicenter studies with quantitative PET.
    Boellaard R
    Methods Mol Biol; 2011; 727():335-49. PubMed ID: 21331942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
    J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
    Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
    Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-FDG-PET/CT of orofacial tumors, a value of whole-body imaging approach.
    Ferda J; Ferdová E; Záhlava J; Walter J; Mukensnabl P; Daum O; Kreuzberg B
    Eur J Radiol; 2010 Feb; 73(2):241-8. PubMed ID: 19101104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
    Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
    J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
    Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.
    Boellaard R; Oyen WJ; Hoekstra CJ; Hoekstra OS; Visser EP; Willemsen AT; Arends B; Verzijlbergen FJ; Zijlstra J; Paans AM; Comans EF; Pruim J
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2320-33. PubMed ID: 18704407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
    Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body 18F-FDG PET/CT: the need for a standardized field of view--a referring-physician aid.
    Huston SF; Abdelmalik AG; Nguyen NC; Farghaly HR; Osman MM
    J Nucl Med Technol; 2010 Sep; 38(3):123-7. PubMed ID: 20724533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET.
    Jackson RS; Schlarman TC; Hubble WL; Osman MM
    J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of 18F-FDG 3D mode PET image quality versus acquisition time.
    Brown C; Dempsey MF; Gillen G; Elliott AT
    Nucl Med Commun; 2010 Mar; 31(3):254-9. PubMed ID: 20032801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redistribution of whole-body energy metabolism by exercise: a positron emission tomography study.
    Masud MM; Fujimoto T; Miyake M; Watanuki S; Itoh M; Tashiro M
    Ann Nucl Med; 2009 Jan; 23(1):81-8. PubMed ID: 19205842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.
    Chen Z; Li X; Li F; Ouyang Q; Yu T
    Eur J Radiol; 2010 Sep; 75(3):329-35. PubMed ID: 20576385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
    Beyer T; Bockisch A; Kühl H; Martinez MJ
    J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Treadmill exercise does not affect image quality on subsequent whole body FDG PET scan".
    Spirnak J
    J Nucl Med; 2011 Dec; 52(12):2020. PubMed ID: 22068896
    [No Abstract]   [Full Text] [Related]  

  • 18. Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments.
    Zijlstra JM; Boellaard R; Hoekstra OS
    Leuk Lymphoma; 2009 Nov; 50(11):1748-9. PubMed ID: 19863171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standards for PET image acquisition and quantitative data analysis.
    Boellaard R
    J Nucl Med; 2009 May; 50 Suppl 1():11S-20S. PubMed ID: 19380405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of PET normalization: striving for count rate uniformity.
    Theodorakis L; Loudos G; Prassopoulos V; Kappas C; Tsougos I; Georgoulias P
    Nucl Med Commun; 2013 Nov; 34(11):1033-45. PubMed ID: 24048410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.